Literature DB >> 3625192

Repeated imipramine enhances sensitivity of the brain dopaminergic system related to exploratory behavior.

A Smiałowski.   

Abstract

The influence of imipramine treatment on apomorphine-induced behavior was studied. Imipramine was administered twice a day for 14 days at 10 mg/kg. The control group received a single dose of imipramine. Both groups were tested at 48 hours after imipramine administration, using open field; the number of line crossings and episodes of rearing and looking into holes were counted as part of the exploratory behavior. Repeated, but not single, administration of imipramine increased the exploratory activity induced by apomorphine injection an effect which was blocked by haloperidol pretreatment. The results indicate that repeated imipramine administration enhances the sensitivity of brain dopamine receptors related to exploratory behavior.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3625192     DOI: 10.1007/BF01244341

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  23 in total

Review 1.  The Open-Field Test: a critical review.

Authors:  R N Walsh; R A Cummins
Journal:  Psychol Bull       Date:  1976-05       Impact factor: 17.737

2.  Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens.

Authors:  J Maj; K Wedzony
Journal:  J Pharm Pharmacol       Date:  1985-05       Impact factor: 3.765

3.  Origin of dopaminergic innervation of the rat hippocampal formation.

Authors:  B Scatton; H Simon; M Le Moal; S Bischoff
Journal:  Neurosci Lett       Date:  1980-06       Impact factor: 3.046

4.  Stimulation of hippocampal dopaminergic receptors: behavioral and electrophysiological effects.

Authors:  A Smiałowski
Journal:  Pol J Pharmacol Pharm       Date:  1985 May-Jun

5.  Repeated imipramine treatment increases the responsivity of the rat hippocampus to dopamine. An in vitro study.

Authors:  A Smiałowski; M Bijak
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

6.  Depression, intellectual impairment, and Parkinson disease.

Authors:  R Mayeux; Y Stern; J Rosen; J Leventhal
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

7.  Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.

Authors:  W Daniel; A Adamus; M Melzacka; J Szymura; J Vetulani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

8.  Is the mesocortical dopaminergic system involved in Parkinson disease?

Authors:  F Javoy-Agid; Y Agid
Journal:  Neurology       Date:  1980-12       Impact factor: 9.910

9.  Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.

Authors:  J S Fink; G P Smith
Journal:  Brain Res       Date:  1980-10-20       Impact factor: 3.252

10.  An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine.

Authors:  P J Fray; B J Sahakian; T W Robbins; G F Koob; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  1 in total

Review 1.  The Michelin red guide of the brain: role of dopamine in goal-oriented navigation.

Authors:  Aude Retailleau; Thomas Boraud
Journal:  Front Syst Neurosci       Date:  2014-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.